Malawi study tests HIV prevention safety for moms and babies
NCT ID NCT06158126
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the safety of two HIV prevention methods (a long-acting shot and daily pills) in pregnant and breastfeeding women in Malawi. About 621 women who are already using or start these drugs during pregnancy will be followed along with their infants. The goal is to see if there are differences in pregnancy problems, mother's health, or baby's health between the two options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bwaila Distict Hospital
RECRUITINGLilongwe, Malawi
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can antimalarials be safely used in early pregnancy? a massive registry seeks answers
- Texts and local mentors: a new way to empower teen girls on contraception?
- Mindfulness during pregnancy: a new way to boost mental health and baby bonding?
- Teaching Moms-to-Be about seafood safety: a new weapon against toxic exposures?
- Can we improve emergency C-Sections for the sickest mothers?
- Can DIY insulin algorithms match commercial systems for pregnant women with type 1 diabetes?